Compare DRUG & WLKP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DRUG | WLKP |
|---|---|---|
| Founded | 2019 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 707.1M | 778.9M |
| IPO Year | 2020 | 2014 |
| Metric | DRUG | WLKP |
|---|---|---|
| Price | $88.01 | $22.90 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $129.25 | N/A |
| AVG Volume (30 Days) | ★ 151.3K | 19.6K |
| Earning Date | 05-15-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 8.25% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | ★ $1,166,695,000.00 |
| Revenue This Year | N/A | $19.48 |
| Revenue Next Year | N/A | $5.24 |
| P/E Ratio | ★ N/A | $15.30 |
| Revenue Growth | N/A | ★ 2.71 |
| 52 Week Low | $23.18 | $17.75 |
| 52 Week High | $123.75 | $23.46 |
| Indicator | DRUG | WLKP |
|---|---|---|
| Relative Strength Index (RSI) | 58.20 | N/A |
| Support Level | $72.06 | N/A |
| Resistance Level | $91.69 | N/A |
| Average True Range (ATR) | 3.92 | 0.00 |
| MACD | -0.24 | 0.00 |
| Stochastic Oscillator | 43.59 | 0.00 |
Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult-to-treat disorders such as resistant epilepsy, treatment-resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
Westlake Chemical Partners LP is a part of the chemical industry in the United States. Its operations are conducted through OpCo, it acquires and develops ethylene production facilities, which convert ethane into ethylene. OpCo sells ethylene and its co-products, such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen, to Westlake and other customers located in the United States. Its assets include three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana.